The proposed experimental study was primarily aimed to identify the consequences of ACE2 inhibition on RBCs of hypertensive rats, and thus to check whether RBC properties could be affected by ACE2 inhibition in an individual suffering from one of the most common cardiovascular risk factors—hypertension. This evidence concerns the gene ACE2 and hypertensive disorder.